A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

Paul Hinds, a cybersecurity expert who likes yoga and bicycling, was diagnosed with prostate cancer about five years ago. He tried multiple treatments before turning to intramuscular shots of Lupron ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...

The FDA is reviewing Abbott’s supplemental New Drug Application for a new six-month 45-mg formulation of Lupron Depot (leuprolide acetate for depot suspension) for the palliative treatment of advanced ...

Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

The FINANCIAL — Abbott Park, Illinois — Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved a new 45 mg for six-month administration formulation of Lupron Depot® ...

When Frank Wurzbacher’s oncologist prescribed monthly Lupron injections to prevent his prostate cancer from recurring, he had no idea the insurance barriers he would face. His insurer initially ...

Dear Dr. Roach: My husband is 89 and taking amiodarone. He had a heart attack and is taking iron infusions for anemia. He was diagnosed with prostate cancer. His PSA level is over 300 ng/mL, but his ...

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care. Following the 2025 European Society of Medical Oncology (ESMO) ...

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical. "I don't date people who don't take care ...